Patients 18 years and older

Primary diagnosis of moderate-severe persistent asthma (as per GINA)

Prescribed inhaled corticosteroid medication (min dose of 250 µg fluticasone equivalent per day) for at least 12 consecutive months

Uncontrolled asthma (≤ 19 on the Asthma Control Test)

Covered by a drug insurance plan (e.g., RAMQ)

Non-adherent to ICS medication (based on having filled less than 30% of their prescriptions over the last year)

Able to speak English or French.

Motivational Interviewing for Medication Adherence in Asthma